Teva enters billion-dollar settlement in US opioid case
The Israeli pharmaceutical firm maintains its innocence in the opioid health crisis in the US but has agreed to pay USD 4.25bn over the next 13 years in a national settlement.
by marketwire, translated by daniel pedersen
Teva has entered a settlement to resolve an abundance of lawsuits filed by state and local governments in the US, according to the firm’s second quarterly report on Tuesday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg&w=384&q=75)
